<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cutaneous leishmaniasis: Epidemiology and control</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cutaneous leishmaniasis: Epidemiology and control</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cutaneous leishmaniasis: Epidemiology and control</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Naomi Aronson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4276440"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Leishmaniasis consists of a complex of vector-borne diseases caused by a heterogeneous group of protozoa belonging to the genus <em>Leishmania</em>; it is transmitted by sand fly vectors. Clinical manifestations range from cutaneous ulcers to systemic multiorgan disease. The epidemiology and control of cutaneous leishmaniasis (CL) are reviewed here. The clinical manifestations, diagnosis, and treatment are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5689.html" rel="external">"Cutaneous leishmaniasis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5686.html" rel="external">"Cutaneous leishmaniasis: Treatment"</a>.)</p><p class="headingAnchor" id="H4275499"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H1555814323"><span class="h2">General principles</span><span class="headingEndMark"> — </span><em>Leishmania</em> infection is endemic in scattered foci in more than 98 countries on five continents [<a href="#rid1">1</a>]. As of 2022, 99 countries reported endemic cutaneous leishmaniasis (CL) [<a href="#rid2">2,3</a>]. Globally, the annual incidence of CL is estimated to be 0.7 to 1 million new cases per year [<a href="#rid4">4</a>]. The 2019 Global Burden of Disease study estimated 4.6 million prevalent CL cases [<a href="#rid5">5</a>]. In 2022, approximately 85 percent of CL is reported from eight countries: Afghanistan, Algeria, Brazil, Colombia, Islamic Republic of Iran, Iraq, Peru, and the Syrian Arab Republic  (<a class="graphic graphic_figure graphicRef110869" href="/z/d/graphic/110869.html" rel="external">figure 1</a>) [<a href="#rid2">2</a>]. Detailed global distribution maps (1960 to 2020) have been published [<a href="#rid6">6-8</a>].</p><p>At least 23 species of <em>Leishmania</em> have been associated with human infection [<a href="#rid9">9</a>]. In general, leishmaniasis is transmitted by the bite of an infected female sand fly to mammalian reservoirs (typically rodents, sloths, marsupials, or wild or domestic canines)  (<a class="graphic graphic_figure graphicRef71680" href="/z/d/graphic/71680.html" rel="external">figure 2</a>). Humans are infected incidentally when they enter endemic areas. Anthroponotic (human-sand fly-human) transmission of <em>Leishmania tropica</em> in urban areas (Kabul, Afghanistan) has been described [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H4275514"><span class="h2">Emergence outside endemic areas</span><span class="headingEndMark"> — </span>The number of CL cases imported into nonendemic developed countries increased during the 1990s and 2000s. Review of data from the GeoSentinel surveillance database demonstrated that between 1996 and 2004, CL was among the 10 most common dermatologic disorders among returning travelers from Central and South America [<a href="#rid11">11,12</a>]. Among United States GeoSentinel sites between 2008 and 2019, 111 CL cases and 6 mucosal leishmaniasis cases were reported [<a href="#rid13">13</a>]. Between 1997 and 2017 in the entire GeoSentinel study, 858 returned travelers had travel-acquired CL or mucosal leishmaniasis. Notably, 10 percent of the individuals with CL traveled for ≤2 weeks. Bolivia and Costa Rica were the destination countries associated with the highest number of CL cases (18 and 11 percent, respectively) [<a href="#rid14">14</a>]. </p><p>Similarly, the Hospital for Tropical Diseases in London identified 223 patients with CL between 1998 and 2009 [<a href="#rid15">15</a>]. Old World CL was observed in 90 patients; it mostly occurred among travelers to the Mediterranean region and was caused by <em>L.L. infantum </em>(<em>syn chagasi</em>). New World CL was observed in 133 patients; 73 percent was caused by <em>Leishmania Viannia</em> species and it mostly occurred among backpackers or soldiers in jungle training. There were also 11 cases of mucosal leishmaniasis (ML); other reports have also described recognition of ML among young, healthy adventure travelers to Central and South America [<a href="#rid15">15,16</a>].</p><p>Military operations in Iraq and Afghanistan have been associated with outbreaks of Old World CL among military personnel. It is estimated that more than 2000 cases have occurred among United States personnel, based on samples submitted to the Leishmaniasis Diagnostics Laboratory at the Walter Reed Army Institute of Research. Infections acquired in Iraq are mainly due to <em>L.L. major</em>; infections acquired in Afghanistan are due to both <em>L.L. major</em> and <em>L.L. tropica</em>. Many cases of <em>L.L. major</em> infection acquired around Mazar-e-Sharif, Afghanistan, were complicated by lymphocutaneous invasion [<a href="#rid17">17,18</a>]. Rarely, cutaneous <em>L.L. infantum (syn chagasi)</em> infection has been observed.</p><p>Leishmaniasis and conflict have long been linked. Outbreaks in Afghanistan, Iran, Iraq, Colombia, and most recently the Syrian Arab Republic are illustrative of this. Conflict in the Syrian Arab Republic and the resultant effects on health infrastructure and mass displacement has led to epidemic CL [<a href="#rid19">19-22</a>]<em>.</em> This has caused outbreaks in Lebanon, Jordan, and Turkey among refugees [<a href="#rid23">23-25</a>]. Surveillance among adult Syrian refugees evaluated for migration-related illness found 32 percent had CL [<a href="#rid26">26</a>].</p><p>The clinical presentation of <em>L.V. braziliensis</em> in the Corte de Pedra area of northeast Brazil is evolving. Disseminated leishmaniasis is spreading rapidly in this area. This condition is distinct from diffuse CL; it consists of &gt;10 (sometimes up to 300) pleomorphic, acneiform, nodular, or ulcerative lesions in more than two body areas. Frequently, it is much more severe and difficult to treat than localized CL caused by <em>L.V. braziliensis</em> [<a href="#rid27">27,28</a>]. Disseminated leishmaniasis has also been reported in Colombia [<a href="#rid29">29</a>].</p><p>In the United States, more than 80 cases of endemic human CL have been identified as of 2017; all were acquired in Arizona, Texas, or Oklahoma [<a href="#rid30">30,31</a>]. <em>L.L. mexicana</em> was identified in those with species identification, with a novel <em>Leishmania</em> noted in Arizona [<a href="#rid31">31</a>]. In 2014, a 27-month-old boy in North Dakota whose family had emigrated from endemic Nepal prior to his birth developed cutaneous <em>L.L. donovani</em> spp infection of the eyelid [<a href="#rid32">32,33</a>].</p><p>In Australia, CL due to a novel <em>Leishmania </em>species has been identified among red kangaroos, wallabies, and wallaroos; thus far, no human cases have been reported [<a href="#rid34">34-36</a>]. Transmission via a midge vector has been suggested.</p><p>In the French West Indies, a new species of parasite, <em>L. Mundinia martiniquensis</em>, has been reported to cause CL and VL [<a href="#rid37">37,38</a>]. Based on DNA sequence analysis, the parasite in Thailand known as <em>L. Mundinia orientalis</em> has been found to be the same subgenus, suggesting a broader geographic distribution than previously known [<a href="#rid39">39</a>]. In Ghana, CL caused by <em>Leishmania enriettii</em> complex was reported [<a href="#rid40">40,41</a>].</p><p>As use of biologic immunomodulating treatments expands, reports of CL associated with tumor necrosis factor-alpha inhibitor use and atypical presentations in travelers have been observed [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H4276291"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>CL in the New World is generally caused by <em>L.L. mexicana</em> and parasites from the <em>Viannia</em> complex  (<a class="graphic graphic_table graphicRef86988" href="/z/d/graphic/86988.html" rel="external">table 1</a>). CL in the Old World is generally caused by <em>L.L. major</em>, <em>L.L. tropica</em>, or <em>L.L. aethiopica</em>. Species associated with visceral leishmaniasis, <em>L.L. infantum (syn chagasi)</em> and <em>L.L. donovani</em>, may also cause localized CL. (See  <a class="medical medical_review" href="/z/d/html/5732.html" rel="external">"Visceral leishmaniasis: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H4276317"><span class="h1">LIFECYCLE</span><span class="headingEndMark"> — </span>Leishmaniasis is transmitted by the bite of an infected female sand fly to a mammalian reservoir (typically rodents, sloths, marsupials, or wild or domestic canines)  (<a class="graphic graphic_figure graphicRef71680" href="/z/d/graphic/71680.html" rel="external">figure 2</a>).</p><p><em>Leishmania</em> persist as obligate intracellular parasites (in the amastigote form) in macrophages of mammalian host tissues. Feeding sand fly vectors ingest amastigotes; over the next 4 to 14 days, amastigotes develop into motile, flagellated extracellular promastigote parasites in the gut of the sand fly. Promastigote parasites are subsequently regurgitated from the proboscis of the sand fly into the skin of the next mammalian host during feeding. These promastigotes are phagocytized and transformed to amastigotes within phagolysosomes, perpetuating the transmission cycle.</p><p class="headingAnchor" id="H4276343"><span class="h2">Sand fly vectors</span><span class="headingEndMark"> — </span>Phlebotomine sand flies of two genera transmit CL: <em>Lutzomyia</em> in the New World and <em>Phlebotomus</em> in the Old World [<a href="#rid43">43</a>]. More than 90 sand fly species are proven or probable vectors [<a href="#rid9">9</a>].</p><p>Sand flies are generally nocturnal feeders, but some species in South America may feed preferentially during the day. Most species are capable of feeding during the day if disturbed. Sand flies are relatively poor fliers; they are easily disturbed by wind and live close to animal reservoirs for perpetuation of transmission.</p><p>Sand flies probe with slashing mouthparts that allow blood to pool below the skin surface. Infected sand flies regurgitate metacyclic <em>Leishmania</em> parasites, saliva, and promastigote secretory gel (PSG) into this blood pool. Sand fly saliva and PSG provide immunomodulatory changes at the infection site, which may exacerbate infection [<a href="#rid44">44-47</a>].</p><p class="headingAnchor" id="H4276350"><span class="h2">Transmission to humans</span><span class="headingEndMark"> — </span>Transmission of CL can follow epidemic or endemic patterns. Outbreaks may occur when a sand fly habitat is disturbed (such as encroachment of settlements into forested areas of the Amazon) or when susceptible hosts move into areas of endemic transmission (for example, outbreaks of CL have occurred among military personnel deployed to Iraq and Afghanistan).</p><p>The global prevalence of CL is increasing because of many factors, including climate change, urbanization/deforestation, increasing rodent populations, decreasing insecticide use, war, mass population displacement/migration, adventure travel, and increasing numbers of immunosuppressed hosts.</p><p>Humans may represent a source of infection; viable parasites have been recovered from blood and uninvolved skin both before and after treatment [<a href="#rid48">48-50</a>]. The implications for transfusion/tissue donation remain to be explored, although the risk of human-to-human transmission is likely much lower than for visceral leishmaniasis.</p><p class="headingAnchor" id="H4276132"><span class="h1">CONTROL</span><span class="headingEndMark"> — </span>Prevention of CL consists of individual protective measures and public health measures. There is no effective preexposure prophylaxis or effective vaccine. Prior infection confers some immunity against the infecting <em>Leishmania </em>species, which suggests promise for vaccine development [<a href="#rid51">51</a>]. Leishmanization, a strategy previously used in some regions at risk for <em>L.L. major</em> infection, consisted of injecting viable parasites to produce a controlled skin lesion and induce T cell immunity. This strategy had some efficacy, but there was variability between lots and not all skin lesions healed fully. A cost-effective analysis (using a societal perspective with costs per disability adjusted life year) found that a training program leading to improved CL early diagnosis and the interruption of vector transmission were cost effective [<a href="#rid52">52</a>].</p><p>Effective prevention requires health education regarding risk of infection and epidemiology of transmission. Infection is transmitted by sand fly bites usually between dusk and dawn. Covering skin with clothing is helpful as sand fly mouthparts do not penetrate clothing (in contrast, mosquito mouthparts do penetrate clothing). Clothing can be impregnated with an insecticide such as <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a>. An insect repellent such as DEET (NN-diethyl-3-methylbenzamide) can be applied to exposed skin areas. Use of fine mesh insecticide-treated bednets may also be helpful [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/z/d/html/4085.html" rel="external">"Prevention of arthropod and insect bites: Repellents and other measures"</a>.)</p><p>Public health measures for prevention of CL consist of vector control (sand flies) and reservoir control (domestic and sylvatic animals) [<a href="#rid54">54</a>]. A review of preventive measures noted that few human-specific outcomes have been measured for any intervention [<a href="#rid55">55</a>]. One cluster-randomized clinical trial in Afghanistan showed that indoor residual spraying with lambdacyhalotrhin, insecticide-treated bednets, and insecticide-treated bedsheets were all associated with a significant reduction in CL cases [<a href="#rid56">56</a>]. In settings with peridomiciliary transmission, residual insecticide spraying may be effective; the efficacy depends on transmission dynamics in a local area [<a href="#rid57">57</a>]. A pilot comparative trial of insecticidal wall painting, insecticidal durable wall lining, insecticide impregnated bednets, and indoor residual spraying with deltamethrin suggested that insecticidal walling painting resulted in reduced sand fly numbers [<a href="#rid58">58</a>]. Effective interventions have included clearing vegetation, eliminating reservoir habitats such as rodent burrows, placing wall barriers, and using insecticide diffusers or coils in living areas [<a href="#rid59">59,60</a>]. Animal reservoir control may not be practical in areas where sylvatic rodents serve as the major reservoir. The use of deltametrin-impregnated collars in dogs has been associated with decreased seroconversion rates of visceral leishmaniasis in humans and dogs, but its efficacy for prevention of CL has not been evaluated [<a href="#rid61">61</a>].</p><p class="headingAnchor" id="H4275882"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> − Leishmaniasis consists of a complex of vector-borne diseases caused by protozoa belonging to the genus <em>Leishmania</em>  (<a class="graphic graphic_table graphicRef86988" href="/z/d/graphic/86988.html" rel="external">table 1</a>). Cutaneous leishmaniasis (CL) in the New World is generally caused by <em>L.L. mexicana</em> and parasites from the <em>Viannia</em> complex. CL in the Old World is generally caused by <em>L.L. major</em>, <em>L.L. tropica</em>, or <em>L.L. aethiopica</em>. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lifecycle</strong> − Leishmaniasis is transmitted by the bite of an infected female sand fly to a mammalian reservoir  (<a class="graphic graphic_figure graphicRef71680" href="/z/d/graphic/71680.html" rel="external">figure 2</a>). Sand flies are generally nocturnal feeders but are capable of feeding during the day. Transmission of CL can follow epidemic or endemic patterns. Outbreaks may occur when a sand fly habitat is disturbed or when susceptible hosts move into areas of endemic transmission. (See <a class="local">'Lifecycle'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> − Leishmania infection is endemic in scattered foci in more than 98 countries on 5 continents. Globally, the annual incidence of CL is estimated to be 0.7 to 1.0 million new cases per year. Approximately 85 percent of CL is reported from eight countries: Afghanistan, Algeria, Brazil, Colombia, Iraq, Islamic Republic of Iran, Peru, and the Syrian Arab Republic. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Individual preventive measures</strong> − Individual protective measures for prevention of CL include covering skin with clothing; clothing can also be impregnated with insecticide such as <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a>. Insect repellent can be applied to exposed skin areas. Use of fine mesh insecticide-treated bednets may also be helpful. (See <a class="local">'Control'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vector and reservoir control</strong> − Public health measures for prevention of CL consist of vector control (sand flies) and reservoir control (domestic and sylvatic animals). Residual insecticide spraying may be effective in settings with peridomiciliary transmission. Other interventions have included clearing vegetation, eliminating reservoir habitats such as rodent burrows, placing wall barriers, and using insecticide diffusers or coils in living areas. (See <a class="local">'Control'</a> above.)</p><p></p><p class="headingAnchor" id="H11808057"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. Karin Leder, who contributed to an earlier version of this topic review.</p><p>The content and views expressed in this publication are the sole responsibility of the author and do not necessarily reflect the views or policies of the Department of Defense or the US Government. Mention of trade names, commercial products, or organizations does not imply endorsement by the US Government.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">World Health Organization. Essential leishmaniasis maps. http://www.who.int/leishmaniasis/leishmaniasis_maps/en/ (Accessed on September 06, 2012).</li><li class="breakAll">Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years. World Health Organization. Available at: https://www.who.int/publications/i/item/who-wer9840-471-487 (Accessed on October 08, 2023).</li><li class="breakAll">Global leishmaniasis surveillance: 2019–2020, a baseline for the 2030 roadmap. Geneva: World Health Organization. 2020. Available at: https://www.who.int/publications/i/item/who-wer9635-401-419 (Accessed on December 17, 2021).</li><li class="breakAll">The World Health Organization. Leishmaniasis fact sheet. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis (Accessed on January 04, 2022).</li><li class="breakAll">Institute for Health Metrics and Evaluation. Findings from the Global Burden of Disease Study 2019. https://www.healthdata.org/gbd/2019 (Accessed on January 04, 2022).</li><li><a class="nounderline abstract_t">Pigott DM, Bhatt S, Golding N, et al. Global distribution maps of the leishmaniases. Elife 2014; 3.</a></li><li><a class="nounderline abstract_t">Pigott DM, Golding N, Messina JP, et al. Global database of leishmaniasis occurrence locations, 1960-2012. Sci Data 2014; 1:140036.</a></li><li class="breakAll">Global leishmaniasis surveillance: 2019–2020, a baseline for the 2030 roadmap. Geneva: World Health Organization. 2020. https://www.who.int/publications/i/item/who-wer9635-401-419 (Accessed on December 17, 2021).</li><li class="breakAll">WHO Technical Report Series 949. “Control of the Leishmaniases.” 2010. http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf (Accessed on September 04, 2012).</li><li><a class="nounderline abstract_t">Reithinger R, Mohsen M, Leslie T. Risk factors for anthroponotic cutaneous Leishmaniasis at the household level in Kabul, Afghanistan. PLoS Negl Trop Dis 2010; 4:e639.</a></li><li><a class="nounderline abstract_t">Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119.</a></li><li><a class="nounderline abstract_t">Lederman ER, Weld LH, Elyazar IR, et al. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis 2008; 12:593.</a></li><li><a class="nounderline abstract_t">Curtin JM, Aronson NE. Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity. Microorganisms 2021; 9.</a></li><li><a class="nounderline abstract_t">Boggild AK, Caumes E, Grobusch MP, et al. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis. J Travel Med 2019; 26.</a></li><li><a class="nounderline abstract_t">Wall EC, Watson J, Armstrong M, et al. Epidemiology of imported cutaneous leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: use of polymerase chain reaction to identify the species. Am J Trop Med Hyg 2012; 86:115.</a></li><li><a class="nounderline abstract_t">Lawn SD, Whetham J, Chiodini PL, et al. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM 2004; 97:781.</a></li><li><a class="nounderline abstract_t">van Thiel PP, Leenstra T, de Vries HJ, et al. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment. Am J Trop Med Hyg 2010; 83:1295.</a></li><li class="breakAll">Aronson N. Leishmaniasis in American soldiers: Parasites from the front. In: Emerging Infections 7, Scheld W, Hooper D, Hughes J (Eds), ASM Press, Washington, DC 2007. p.325.</li><li><a class="nounderline abstract_t">Hayani K, Dandashli A, Weisshaar E. Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war. Acta Derm Venereol 2015; 95:62.</a></li><li><a class="nounderline abstract_t">Saroufim M, Charafeddine K, Issa G, et al. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerg Infect Dis 2014; 20:1712.</a></li><li><a class="nounderline abstract_t">Alasaad S. War diseases revealed by the social media: massive leishmaniasis outbreak in the Syrian Spring. Parasit Vectors 2013; 6:94.</a></li><li><a class="nounderline abstract_t">Du R, Hotez PJ, Al-Salem WS, Acosta-Serrano A. Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa. PLoS Negl Trop Dis 2016; 10:e0004545.</a></li><li><a class="nounderline abstract_t">Alawieh A, Musharrafieh U, Jaber A, et al. Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak. Int J Infect Dis 2014; 29:115.</a></li><li><a class="nounderline abstract_t">Inci R, Ozturk P, Mulayim MK, et al. Effect of the Syrian Civil War on Prevalence of Cutaneous Leishmaniasis in Southeastern Anatolia, Turkey. Med Sci Monit 2015; 21:2100.</a></li><li><a class="nounderline abstract_t">His Excellency, Murshidi MM, Hijjawi MQ, et al. Syrian refugees and Jordan's health sector. Lancet 2013; 382:206.</a></li><li><a class="nounderline abstract_t">Mockenhaupt FP, Barbre KA, Jensenius M, et al. Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015. Euro Surveill 2016; 21:30160.</a></li><li><a class="nounderline abstract_t">Turetz ML, Machado PR, Ko AI, et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 2002; 186:1829.</a></li><li><a class="nounderline abstract_t">Schriefer A, Guimarães LH, Machado PR, et al. Geographic clustering of leishmaniasis in northeastern Brazil. Emerg Infect Dis 2009; 15:871.</a></li><li><a class="nounderline abstract_t">Vélez ID, Jiménez A, Vásquez D, Robledo SM. Disseminated Cutaneous Leishmaniasis in Colombia: Report of 27 Cases. Case Rep Dermatol 2015; 7:275.</a></li><li><a class="nounderline abstract_t">McIlwee BE, Weis SE, Hosler GA. Incidence of Endemic Human Cutaneous Leishmaniasis in the United States. JAMA Dermatol 2018; 154:1032.</a></li><li><a class="nounderline abstract_t">de Almeida M, Zheng Y, Nascimento FS, et al. Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA. Emerg Infect Dis 2021; 27:1714.</a></li><li><a class="nounderline abstract_t">Clarke CF, Bradley KK, Wright JH, Glowicz J. Case report: Emergence of autochthonous cutaneous leishmaniasis in northeastern Texas and southeastern Oklahoma. Am J Trop Med Hyg 2013; 88:157.</a></li><li><a class="nounderline abstract_t">Douvoyiannis M, Khromachou T, Byers N, et al. Cutaneous leishmaniasis in North Dakota. Clin Infect Dis 2014; 59:e73.</a></li><li><a class="nounderline abstract_t">Rose K, Curtis J, Baldwin T, et al. Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms. Int J Parasitol 2004; 34:655.</a></li><li><a class="nounderline abstract_t">Dougall A, Shilton C, Low Choy J, et al. New reports of Australian cutaneous leishmaniasis in Northern Australian macropods. Epidemiol Infect 2009; 137:1516.</a></li><li><a class="nounderline abstract_t">Panahi E, Stanisic DI, Skinner EB, et al. Detection of Leishmania (Mundinia) macropodum (Kinetoplastida: Trypanosomatidae) and heterologous Leishmania species antibodies among blood donors in a region of Australia with marsupial Leishmania endemicity. Int J Infect Dis 2023; 130:42.</a></li><li><a class="nounderline abstract_t">Desbois N, Pratlong F, Quist D, Dedet JP. Leishmania (Leishmania) martiniquensis n. sp. (Kinetoplastida: Trypanosomatidae), description of the parasite responsible for cutaneous leishmaniasis in Martinique Island (French West Indies). Parasite 2014; 21:12.</a></li><li><a class="nounderline abstract_t">Sereno D. Leishmania (Mundinia) spp.: from description to emergence as new human and animal Leishmania pathogens. New Microbes New Infect 2019; 30:100540.</a></li><li><a class="nounderline abstract_t">Pothirat T, Tantiworawit A, Chaiwarith R, et al. First isolation of Leishmania from Northern Thailand: case report, identification as Leishmania martiniquensis and phylogenetic position within the Leishmania enriettii complex. PLoS Negl Trop Dis 2014; 8:e3339.</a></li><li><a class="nounderline abstract_t">World Health Organization. Global leishmaniasis surveillance update, 1998-2016. Wkly Epidemiol Rec 2018; 40:530.</a></li><li><a class="nounderline abstract_t">Kwakye-Nuako G, Mosore MT, Duplessis C, et al. First isolation of a new species of Leishmania responsible for human cutaneous leishmaniasis in Ghana and classification in the Leishmania enriettii complex. Int J Parasitol 2015; 45:679.</a></li><li><a class="nounderline abstract_t">van Griensven J, Carrillo E, López-Vélez R, et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 2014; 20:286.</a></li><li><a class="nounderline abstract_t">Killick-Kendrick R. Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol 1990; 4:1.</a></li><li><a class="nounderline abstract_t">Rogers ME, Ilg T, Nikolaev AV, et al. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 2004; 430:463.</a></li><li><a class="nounderline abstract_t">Kamhawi S. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect 2000; 2:1765.</a></li><li><a class="nounderline abstract_t">Andrade BB, de Oliveira CI, Brodskyn CI, et al. Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scand J Immunol 2007; 66:122.</a></li><li><a class="nounderline abstract_t">Abdeladhim M, Kamhawi S, Valenzuela JG. What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infect Genet Evol 2014; 28:691.</a></li><li><a class="nounderline abstract_t">Nakkash-Chmaisse H, Makki R, Nahhas G, et al. Detection of Leishmania parasites in the blood of patients with isolated cutaneous leishmaniasis. Int J Infect Dis 2011; 15:e491.</a></li><li><a class="nounderline abstract_t">de Oliveira Camera P, Junger J, do Espírito Santo Silva Pires F, et al. Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis. Trans R Soc Trop Med Hyg 2006; 100:1112.</a></li><li><a class="nounderline abstract_t">Vergel C, Palacios R, Cadena H, et al. Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis 2006; 194:503.</a></li><li><a class="nounderline abstract_t">Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 2001; 14:229.</a></li><li><a class="nounderline abstract_t">Orellano PW, Vazquez N, Salomon OD. Cost-effectiveness of prevention strategies for American tegumentary leishmaniasis in Argentina. Cad Saude Publica 2013; 29:2459.</a></li><li><a class="nounderline abstract_t">Courtenay O, Gillingwater K, Gomes PA, et al. Deltamethrin-impregnated bednets reduce human landing rates of sandfly vector Lutzomyia longipalpis in Amazon households. Med Vet Entomol 2007; 21:168.</a></li><li><a class="nounderline abstract_t">González U, Pinart M, Sinclair D, et al. Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev 2015; :CD008736.</a></li><li><a class="nounderline abstract_t">Stockdale L, Newton R. A review of preventative methods against human leishmaniasis infection. PLoS Negl Trop Dis 2013; 7:e2278.</a></li><li><a class="nounderline abstract_t">Reyburn H, Ashford R, Mohsen M, et al. A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan. Trans R Soc Trop Med Hyg 2000; 94:361.</a></li><li><a class="nounderline abstract_t">Claborn DM. The biology and control of leishmaniasis vectors. J Glob Infect Dis 2010; 2:127.</a></li><li><a class="nounderline abstract_t">Ghosh D, Alim A, Huda MM, et al. Comparison of Novel Sandfly Control Interventions: A Pilot Study in Bangladesh. Am J Trop Med Hyg 2021; 105:1786.</a></li><li><a class="nounderline abstract_t">Faulde M, Schrader J, Heyl G, Hoerauf A. High efficacy of integrated preventive measures against zoonotic cutaneous leishmaniasis in northern Afghanistan, as revealed by Quantified Infection Rates. Acta Trop 2009; 110:28.</a></li><li><a class="nounderline abstract_t">Warburg A, Faiman R. Research priorities for the control of phlebotomine sand flies. J Vector Ecol 2011; 36 Suppl 1:S10.</a></li><li><a class="nounderline abstract_t">Gavgani AS, Hodjati MH, Mohite H, Davies CR. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002; 360:374.</a></li></ol></div><div id="topicVersionRevision">Topic 87186 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.who.int/leishmaniasis/leishmaniasis_maps/en/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : World Health Organization. Essential leishmaniasis maps. http://www.who.int/leishmaniasis/leishmaniasis_maps/en/ (Accessed on September 06, 2012).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.who.int/publications/i/item/who-wer9840-471-487" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years. World Health Organization. Available at: https://www.who.int/publications/i/item/who-wer9840-471-487 (Accessed on October 08, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.who.int/publications/i/item/who-wer9635-401-419" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Global leishmaniasis surveillance: 2019–2020, a baseline for the 2030 roadmap. Geneva: World Health Organization. 2020. Available at: https://www.who.int/publications/i/item/who-wer9635-401-419 (Accessed on December 17, 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.who.int/news-room/fact-sheets/detail/leishmaniasis" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The World Health Organization. Leishmaniasis fact sheet. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis (Accessed on January 04, 2022).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.healthdata.org/gbd/2019" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Institute for Health Metrics and Evaluation. Findings from the Global Burden of Disease Study 2019. https://www.healthdata.org/gbd/2019 (Accessed on January 04, 2022).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24972829" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Global distribution maps of the leishmaniases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25984344" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Global database of leishmaniasis occurrence locations, 1960-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25984344" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Global database of leishmaniasis occurrence locations, 1960-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25984344" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Global database of leishmaniasis occurrence locations, 1960-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20351787" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Risk factors for anthroponotic cutaneous Leishmaniasis at the household level in Kabul, Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16407507" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Spectrum of disease and relation to place of exposure among ill returned travelers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18343180" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33799892" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31553455" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22232460" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Epidemiology of imported cutaneous leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: use of polymerase chain reaction to identify the species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15569809" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21118937" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21118937" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25342106" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25279543" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23587258" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : War diseases revealed by the social media: massive leishmaniasis outbreak in the Syrian Spring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27227772" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25449245" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26190279" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Effect of the Syrian Civil War on Prevalence of Cutaneous Leishmaniasis in Southeastern Anatolia, Turkey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23830357" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Syrian refugees and Jordan's health sector.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26987893" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12447770" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19523284" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Geographic clustering of leishmaniasis in northeastern Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26557074" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Disseminated Cutaneous Leishmaniasis in Colombia: Report of 27 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30046836" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Incidence of Endemic Human Cutaneous Leishmaniasis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34013870" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23185078" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Case report: Emergence of autochthonous cutaneous leishmaniasis in northeastern Texas and southeastern Oklahoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24850800" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cutaneous leishmaniasis in North Dakota.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15111087" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19288959" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : New reports of Australian cutaneous leishmaniasis in Northern Australian macropods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36241162" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Detection of Leishmania (Mundinia) macropodum (Kinetoplastida: Trypanosomatidae) and heterologous Leishmania species antibodies among blood donors in a region of Australia with marsupial Leishmania endemicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24626346" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Leishmania (Leishmania) martiniquensis n. sp. (Kinetoplastida: Trypanosomatidae), description of the parasite responsible for cutaneous leishmaniasis in Martinique Island (French West Indies).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31061710" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Leishmania (Mundinia) spp.: from description to emergence as new human and animal Leishmania pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25474647" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : First isolation of Leishmania from Northern Thailand: case report, identification as Leishmania martiniquensis and phylogenetic position within the Leishmania enriettii complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Global leishmaniasis surveillance update, 1998-2016</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26099650" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : First isolation of a new species of Leishmania responsible for human cutaneous leishmaniasis in Ghana and classification in the Leishmania enriettii complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24450618" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Leishmaniasis in immunosuppressed individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2132963" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Phlebotomine vectors of the leishmaniases: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15269771" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11137049" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635789" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Role of sand fly saliva in human and experimental leishmaniasis: current insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25117872" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21621442" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Detection of Leishmania parasites in the blood of patients with isolated cutaneous leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16765391" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16845635" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11292637" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Leishmaniasis: current status of vaccine development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356692" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Cost-effectiveness of prevention strategies for American tegumentary leishmaniasis in Argentina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17550436" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Deltamethrin-impregnated bednets reduce human landing rates of sandfly vector Lutzomyia longipalpis in Amazon households.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26246011" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Vector and reservoir control for preventing leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23818997" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : A review of preventative methods against human leishmaniasis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11127233" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20606968" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The biology and control of leishmaniasis vectors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34695792" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Comparison of Novel Sandfly Control Interventions: A Pilot Study in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19161965" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : High efficacy of integrated preventive measures against zoonotic cutaneous leishmaniasis in northern Afghanistan, as revealed by Quantified Infection Rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21366761" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Research priorities for the control of phlebotomine sand flies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12241778" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
